Review Article
Usefulness of Whole-Body Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Neurofibromatosis Type 1: A Systematic Review
Table 1
Characteristics of the included articles and patients.
| Authors | Journal | Year | Country | PET device | Number of patients with neurogenic tumors who performed PET (in brackets patients with NF1) | Sex (% male) | Mean age (years) | Number of neurogenic tumor lesions evaluated |
| Ferner et al. [9] | J Neurol Neurosurg Psychiatry | 2000 | UK | PET | 18 (18) | 44% | 28 | 23 | Cardona et al. [10] | Eur J Surg Oncol | 2003 | Germany | PET | 13 (5) | 38% | 46 | 25 | Wegner et al. [11] | Eur J Nucl Med Mol Imaging | 2005 | UK | PET | 13 (n.a.) | 46% | 15 | n.a. | Brenner et al. [12] | Eur J Nucl Med Mol Imaging | 2006 | Germany | PET | 16 (16) | 44% | 32 | 16 | Bensaid et al. [13] | Ann Dermatol Venereol | 2007 | France | PET | 38 (38) | n.a. | n.a. | 49 | Bredella et al. [14] | AJR Am J Roentgenol | 2007 | USA | PET and PET/CT | 45 (45) | 49% | 37 | 50 | Ferner et al. [15] | Ann Oncol | 2008 | UK | PET and PET/CT | 105 (105) | 48% | 31 | 114 | Fisher et al. [16] | J Neurooncol | 2008 | USA | PET | 18 (18) | 50% | 14 | 19 | Karabatsou et al. [17] | Neurosurgery | 2009 | Canada | PET/CT | 9 (9) | 55% | 38 | 9 | Warbey et al. [18] | Eur J Nucl Med Mol Imaging | 2009 | UK | PET/CT | 62 (62) | 50% | 31 | 85 | Benz et al. [19] | Cancer | 2010 | Germany/USA | PET/CT | 34 (5) | 59% | 46 | 40 | Moharir et al. [20] | Eur J Nucl Med Mol Imaging | 2010 | Canada/Australia | PET/CT | 18 (18) | 44% | 8 | 35 |
|
|
n.a.: not applicable.
|